Hemodialysis (HD) vascular access dysfunction is currently a huge clinical problem for which there are no effective therapies. There are, however, a number of promising technologies that are currently at the experimental or clinical trial stage. We believe that the application of these novel technologies in combination with better clinical protocols for vascular access care could significantly reduce the current problems associated with HD vascular access.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/112972980901000101 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!